The results revealed a significant increase in the level of CD16+NKG2D+ cells in the PBMC+G2 group compared with the PBMC group in CRC PBMCs (p < 0.001) as well as normal PBMCs (p < 0.01). The gene discussed is KLRK1; the disease is colorectal carcinoma.